Results 41 to 50 of about 57,638 (161)
Background. Still, cancer remains to be one of the main causes of death globally. Sesquiterpene lactones (SLs) appeared to have remarkable pharmacologic properties, particularly as anticancer.
Abazar Roustazadeh +6 more
doaj +1 more source
Introduction. Monitoring is an important tool for managing the epidemic of noncommunicable diseases (NCD). The insufficiency of the measures taken to create and strengthen national systems of epidemiological surveillance for noncommunicable diseases is ...
E. O Korotkova, N. N. Kamynina
doaj
Background The double burden of infectious diseases coupled with noncommunicable diseases poses unique challenges for priority setting and for achieving equitable action to address the major causes of disease burden in health systems already impacted by ...
Beverley M. Essue, Lydia Kapiriri
doaj +1 more source
Governance of noncommunicable diseases in Afghanistan
AbstractBackgroundNoncommunicable diseases (NCDs) are the main reasons of mortality worldwide. One of every two person is dying due to NCDs in Afghanistan. International policy actors, mainly the World Health Organization (WHO), published several reports and declarations on controlling and preventing NCDs.
Narges Neyazi +3 more
openaire +3 more sources
Background Tobacco surveys of past decades show that tobacco use prevalence is high in Georgia; According to nationwide Noncommunicable Diseases (NCDC) Risk Factors STEPS Survey 2010 30% of adult population are current tobacco users.
Nino Maglaklelidze +3 more
doaj +1 more source
Objectives: To map the evidence on the barriers to and facilitators of diagnosing noncommunicable diseases among people living with HIV in low- and middle-income countries in Africa.
Abebe Sorsa Badacho +3 more
doaj +1 more source
Background: Pulmonary tuberculosis remains a leading infectious disease globally. In Indonesia, coexisting noncommunicable diseases are increasing referral care use and total spending in the National Health Insurance program.
Danik Iga Prasiska +2 more
doaj +1 more source
Anti-Obesity Pharmacotherapy: Closing the Access Gap Through Local Manufacturing [PDF]
The global obesity epidemic, affecting approximately 890 million adults, has catalyzed substantial advances in pharmacological management. Contemporary anti-obesity medications, including GLP-1 receptor agonists, dual GLP-1/GIP agonists, lipase ...
Mojtaba Farjam +2 more
doaj

